Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB) Stock Information | RedChip

Matinas Biopharma Holdings Inc. (NYSE AMERICAN: MTNB) Listen to this Section


$0.14
-0.0131 ( -8.56% ) 2.1M

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

Market Data


Insider Ownership Transactions

Total Amount Purchased: -10,748,976.00 | $ -1,503,781.74

Date Type Amount Purchased Purchaser
2023-12-15 Sale -1000000.00 Liu Hui
2023-12-15 Sale -3500000.00 Jabbour Jerome D
2023-12-15 Sale -1000000.00 Hoover Thomas
2023-12-15 Sale -1200000.00 Ferguson James J. III
2023-12-15 Sale -1300000.00 Matkovits Theresa
2023-12-15 Sale -1000000.00 Kucinski Keith A
2023-11-03 Sale -437244.00 WIKLER MATTHEW
2023-11-03 Sale -437244.00 Corzo Kathryn Penkus
2023-11-03 Sale -437244.00 Scibetta James S
2023-11-03 Sale -437244.00 CONRAD HERBERT J

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 45 Aug 14, 2024
10-q Quarterly Reports 66 Aug 14, 2024
8-k 8K-related 15 May 09, 2024
10-q Quarterly Reports 68 May 09, 2024
8-k 8K-related 20 Apr 05, 2024
8-k 8K-related 43 Mar 28, 2024
8-k 8K-related 15 Mar 27, 2024
10-k Annual reports 89 Mar 27, 2024
8-k 8K-related 17 Mar 25, 2024
8-k 8K-related 15 Mar 22, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.